Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Oct;77(2):196-200.

Functional relationship between high-affinity E receptor and CD2-11.3 epitope

Affiliations

Functional relationship between high-affinity E receptor and CD2-11.3 epitope

E Kontny et al. Immunology. 1992 Oct.

Abstract

The expression of both high-affinity E receptor (EhR) to sheep erythrocytes and CD2-11.3 epitope on activated human T lymphocytes suggests that these two structures may be functionally identical or closely associated. Therefore the aim of the present work was to determine if the CD2-11.3 epitope is involved in the early E rosette formation. The ability of normal and phytohaemagglutin (PHA)-activated human T lymphocytes to express the CD2-11.3 epitope and to form early E rosettes (T cells with EhR) was studied simultaneously. The partial divergence of CD2-11.3 expression on T lymphocytes from the ability of these cells to form early E (Ee) rosettes was found. The results indicated that the expression of CD2-11.3 epitope alone is insufficient to form the Ee rosettes by activated T lymphocytes, yet it may facilitate this phenomenon in the presence of EhR. The above data clearly show that the CD2-11.3 epitope is functionally closely associated although not identical to EhR. Accordingly, it seems that these two structures may co-adhere to the appropriate ligand. Thus it is possible that the CD2-11.3 epitope, as well as its established role in activation signalling, may also act as a co-adhesion molecule.

PubMed Disclaimer

Similar articles

References

    1. Arch Immunol Ther Exp (Warsz). 1990;38(5-6):421-32 - PubMed
    1. J Reticuloendothel Soc. 1981 Feb;29(2):117-25 - PubMed
    1. Arch Immunol Ther Exp (Warsz). 1989;37(5-6):577-86 - PubMed
    1. Annu Rev Immunol. 1987;5:223-52 - PubMed
    1. Ann Immunol (Paris). 1982 Sep-Oct;133D(2):211-8 - PubMed

Publication types

LinkOut - more resources